Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease

Diabetes Care - United States
doi 10.2337/diacare.27.8.1897
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Combination Therapy With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in the Treatment of Patients With Type 2 Diabetes Mellitus

Archives of Internal Medicine
2003English

Effect of Irbesartan Treatment on Plasma and Urinary Markers of Protein Damage in Patients With Type 2 Diabetes and Microalbuminuria

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2020English

The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Efficiency Assessment for Antihypertensive, Hemodynamic, Renal Effects of Adenosine-Converting Enzyme (ACE) Inhibitors and Irbesartan and Impact on Endothelial Disfunction in Patients With Stage II Hypertension

Zaporozhye Medical Journal
2014English

Maximising Antihypertensive Effects of Angiotensin II Receptor Blockers With Thiazide Diuretic Combination Therapy: Focus on Irbesartan/Hydrochlorothiazide

International Journal of Clinical Practice
Medicine
2007English

Endothelial Effects of Antihypertensive Treatment: Focus on Irbesartan

Vascular Health and Risk Management
2008English

Organoprotecive Effects of Angiotensin II Receptor Blockers in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Comparative Analysis of the Anticancer Activity of Angiotensin Receptor Blockers - Irbesartan and Telmisartan

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy